Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
Holding SUPN?
Track your performance easily

Supernus Pharmaceuticals (SUPN) Cash flow

476 Followers

Supernus Pharmaceuticals Cash Flow

SUPN's free cash flow for Q2 2024 was $35.56M. For the 2024 fiscal year, SUPN's free cash flow was decreased by $-5.74M and operating cash flow was $35.62M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 90.24M$ 111.08M$ 116.83M$ 127.13M$ 138.40M$ 143.13M
Investing Cash Flow
$ -4.50M$ 268.73M$ -216.66M$ -81.91M$ -34.70M$ -157.92M
Financing Cash Flow
$ -475.92M$ -397.88M$ -10.48M$ -130.42M$ 3.56M$ 3.93M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 136.74M$ 75.05M$ 93.12M$ 203.43M$ 288.64M$ 181.38M
Income Tax Paid Supplemental Data
$ 47.61M$ 36.60M$ 16.20M$ 25.19M$ 45.43M$ 51.54M
Interest Paid Supplemental Data
$ 1.95M$ 1.95M$ 2.52M$ 2.52M$ 2.52M$ 2.52M
Issuance Of Capital Stock
$ 6.29M$ 6.61M$ 12.42M$ 7.09M$ 4.36M$ 3.93M
Issuance Of Debt
$ -480.86M$ -402.50M-$ -138.31M$ 0.00$ 0.00
Repayment Of Debt
$ -480.86M$ -495.50M-$ -138.31M$ -802.00K$ 0.00
Free Cash Flow
$ 89.61M$ 111.08M$ 116.83M$ 127.13M$ 134.71M$ 140.39M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Supernus Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis